The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Acoustic biomarkers and AI: Transforming NSCLC detection and personalized care.
 
Chiara Giangregorio
No Relationships to Disclose
 
Cristina Maria Licciardello
No Relationships to Disclose
 
Anthea Iacobucci
No Relationships to Disclose
 
Leonardo Provenzano
Honoraria - Gilead Sciences; Novartis; Pfizer
 
Vanja Miskovic
Speakers' Bureau - Novartis
 
Paolo Ambrosini
No Relationships to Disclose
 
Laura Ferrari
No Relationships to Disclose
 
Andra Diana Dumitrascu
No Relationships to Disclose
 
Laura Mazzeo
Honoraria - MSD; Novartis
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH; LEO Pharma
 
Marco Meazza Prina
No Relationships to Disclose
 
Teresa Beninato
Honoraria - MSD
Travel, Accommodations, Expenses - Lilly; MSD; Pfizer; Sanofi
 
Marta Brambilla
Travel, Accommodations, Expenses - Lilly
 
Claudia Proto
Honoraria - AstraZeneca; BMSi; MSD; Roche
Consulting or Advisory Role - AstraZeneca; Janssen; MSD; Roche; Sanofi
Research Funding - AstraZeneca (Inst); BMSi (Inst); Daiichi Sankyo (Inst); Janssen (Inst); Lilly (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst); Spectrum Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen; MSD; Roche
 
Simona Ferrante
No Relationships to Disclose
 
Giuseppe Lo Russo
Consulting or Advisory Role - Amgen (Inst); AstraZeneca/MedImmune; Bristol-Myers Squibb/Medarex; Daiichi Sankyo/Astra Zeneca; GlaxoSmithKline; Jhonson and Jhonson; Lilly; Merck Serono; MSD; Novartis; Pfizer; Pierre Fabre; REGENERON; Roche; Sanofi; Takeda
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb/Medarex (Inst); Celgene (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); MSD Oncology; MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; BMS; MSD; Roche
 
Emilia Ambrosini
No Relationships to Disclose
 
Alessandra Pedrocchi
Speakers' Bureau - Novartis
 
Marina Garassino
Honoraria - Abbvie; Abion; AstraZeneca; Bayer; BeiGene; Blueprint Genetics (I); BMSi; Boehringer Ingelheim; Celgene; Daiichi Sankyo; Incyte; Janssen; Lilly; Medscape; Merck; Mirati Therapeutics; MSD; Novartis; Oncohost; Pfizer; Regeneron; Roche; Sanofi; Seattle Genetics/Astellas; Takeda
 
Arsela Prelaj
Honoraria - AstraZeneca; BMS; BMS; Janssen
Research Funding - AstraZeneca (Inst); Bayer (Inst); BMS (Inst); Lilly (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Janssen